EASL Clinical Practice Guidelines 2021

Update on the non-invase techniques for the evaluation of liver disease, severity and prognosis.

These new EASL guidelines are a big step forward towards the non-invasive management of patients with liver diseases and provide an unprecedented level of recommendation to Echosens solutions.

These new EASL Guidelines are very prescriptive for FibroScan® parameters.
• LSM by TE receives support from 13 “strong recommendations” and 4 other recommendations or supportive statements.
• CAP™ is now mentioned in the guidelines, with the clear cut-off for steatosis diagnosis.

Link download: https://medigroupasia.com/medical-imaging/education/

Non-invasive evaluation of liver disease severity and prognosis

MediGroup Việt Nam – Partner for life
📲 84 28 39 333 188
📧 info@medigroupasia.com
🌐 http://medigroupasia.com